Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Aurobindo gets USFDA nod for anti-herpes tablets
Business Standard, India
Monday, January 31, 2011 - 8:17am
tags:
Aurobindo, Famciclovir
Courts Clear Way for Consumers to Sue Drug Companies
FairWarning
Monday, January 31, 2011 - 8:16am
tags:
lawsuits
Daiichi Sankyo Profit Grows 34%
WSJ
Monday, January 31, 2011 - 8:13am
tags:
Daiichi Sankyo, earnings
Dr. Reddy’s Provides Update on the Fexofenadine-Pseudoephedrine 24 Hour Litigation
Genetic Engineering News
Monday, January 31, 2011 - 8:12am
tags:
Dr Reddy's, Allegra, Sanofi
Mylan Pharma Nisoldipine ER tablets gets FDA approval
Pharmaceutical Business Review
Monday, January 31, 2011 - 8:10am
tags:
Mylan, Sular, Nisoldipine, Shionogi
Generics Companies Weigh In on Biological Drugs
WSJ
Monday, January 31, 2011 - 8:00am
tags:
biosimilars
Mylan's Matrix Obtains License for Promising HIV/AIDS Treatment
PR-USA.net
Monday, January 31, 2011 - 7:57am
tags:
Mylan, Matrixx, HIV, antiretrovirals, Tibotec, TMC278
Glaxo Settles U.S. Federal Avandia Drug Case
WSJ
Monday, January 31, 2011 - 7:54am
tags:
GSK, Avandia, lawsuits
MorphoSys Reports Clinical Milestones in Pfizer, OncoMed Pacts
Bloomberg
Monday, January 31, 2011 - 7:53am
tags:
MorphoSys, Pfizer, OncoMed
Savient Announces Proposed Offering of $125 Million in Convertible Senior Notes
Yahoo/PR NewsWire
Monday, January 31, 2011 - 7:51am
tags:
Savient
Vanda Pharmaceuticals Files Shelf Registration Statement
Yahoo/PR NewsWire
Monday, January 31, 2011 - 7:50am
tags:
Vanda, stock offering
Repligen Announces Conference Call of Third Quarter Fiscal Year 2011 Results
BusinessWire
Monday, January 31, 2011 - 7:50am
tags:
Repligen, earnings
Genzyme, Sanofi-Aventis Reach Confidentiality Agreement, SEC Filing Shows
Bloomberg
Monday, January 31, 2011 - 7:48am
tags:
Genzyme, Sanofi, M&A
NPS Pharma: Gattex Bowel Study Succeeds
The Street
Monday, January 31, 2011 - 7:47am
tags:
NPS Pharmaceuticals, Gattex, short bowel syndrome
University of Southampton and Inovio Pharmaceuticals Initiate Phase 2 Clinical Study to Evaluate Leukemia DNA Vaccine Using Electroporation Delivery Technology
Yahoo/PR NewsWire
Monday, January 31, 2011 - 7:46am
tags:
Inovio, acute myeloid leukemia, chronic myeloid leukemia, leukemia, Elgen 1000, cancer vaccines
Sanofi-Aventis' Most Promising Clinical Candidate Takes a Nasty Fall
Seeking Alpha
Sunday, January 30, 2011 - 12:23pm
tags:
Sanofi, iniparib, breast cancer, Parp inhibition
Depomed's Stock Price Is a Gift Following FDA Approval of Pain Drug
Seeking Alpha
Sunday, January 30, 2011 - 12:20pm
tags:
Depomed, Gralise, post-herpetic-neuralgia, Lyrica, Pfizer
Novartis Interested in Emerging Market Bolt-On Acquisitions.
WSJ
Sunday, January 30, 2011 - 12:17pm
tags:
Novartis, M&A
Osiris: Finding Opportunity Amongst Uncertainty
Seeking Alpha
Sunday, January 30, 2011 - 12:13pm
tags:
Osiris Therapeutics, Prochymal, stem cells
Pfizer Embraces New Model for Drug Development
Seeking Alpha
Sunday, January 30, 2011 - 12:11pm
tags:
Pfizer, R&D

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.